
Overview
Background
Dr Nagham Ailabouni is a clinician-researcher and NHMRC Emerging Leadership Fellow (EL1) at the University of Queensland, Faculty of Health and Behavioural Sciences.
They identify as a person from a culturally and linguistically diverse background (CALD) and is of Palestinian Jordanian descent. Dr Ailabouni's main research interests include implementation science, co-design and consumer engagement in person-centred deprescribing, quality use of medicines in older people, people living with dementia and their carers.
They completed their undergraduate Pharmacy degree at the University of Otago and is an Australian registered pharmacist with clinical pharmacy experience in various healthcare settings including hospital, aged care and community pharmacy. Thereafter, Dr Ailabouni conferred their PhD titled "Deprescribing in Older New Zealanders" from the University of Otago, Dunedin in 2018. Their PhD program was the first to explore deprescribing in New Zealand.
Dr Ailabouni is the Public Engagement Subcommittee Chair of the leading deprescribing network in Australia, the Australian Deprescribing Network and the co-chair of the American Geriatrics Society Polypharmacy and Deprescribing Special Interest Group. They are the Early Career Representative of the School of Pharmacy representing early career researchers within their institution since 2022.
Professionally, Dr Ailabouni was competitively selected as an observer for the Australian Aged Care Quality and Safety Commission, Medication Safety Oversight Committee, since 2023. They were elected and served as the President of the Pharmaceutical Society of New Zealand (PSNZ) Otago Branch in 2014-2016. They were elected once again and served as the President of the PSNZ South Canterbury Branch in 2016-2018.
Dr Ailabouni enjoys being part of early career researchers' professional development and growth. They are currently supervising and mentoring 6 PhD candidates in Australia and New Zealand and looks forward to growing their supervision roles.
Availability
- Dr Nagham Ailabouni is:
- Available for supervision
Works
Search Professor Nagham Ailabouni’s works on UQ eSpace
2025
Journal Article
What do clinical practice guidelines say about deprescribing? A scoping review
Langford, Aili Veronica, Warriach, Imaan, McEvoy, Aisling M., Karaim, Elisa, Chand, Shyleen, Turner, Justin P., Thompson, Wade, Farrell, Barbara J., Pollock, Danielle, Moriarty, Frank, Gnjidic, Danijela, Ailabouni, Nagham J. and Reeve, Emily (2025). What do clinical practice guidelines say about deprescribing? A scoping review. BMJ Quality and Safety, 34 (1), 28-39. doi: 10.1136/bmjqs-2024-017101
2024
Other Outputs
Defining and evaluating chemical restraint use in Metro North Health
Freeman, Chris, Canning, Martin, Ailabouni, Nagham, Hillen, Jodie, Alker, Hunter, Hart, Grace and Soen, Dicky (2024). Defining and evaluating chemical restraint use in Metro North Health. Brisbane, QLD, Australia: The University of Queensland.
2024
Journal Article
Co-Designing a Consult Patient Decision Aid for Continuation Versus Deprescribing Cholinesterase Inhibitors in People Living with Dementia
Ailabouni, Nagham J., Thompson, Wade, Hilmer, Sarah N., Quirke, Lyntara, McNeece, Janet, Bourke, Alice, Furst, Chloe and Reeve, Emily (2024). Co-Designing a Consult Patient Decision Aid for Continuation Versus Deprescribing Cholinesterase Inhibitors in People Living with Dementia. Drugs & Aging, 41 (10), 821-831. doi: 10.1007/s40266-024-01146-5
2024
Conference Publication
Deprescribing and shared decision-making research
Scott, Sion, Weir, Kristie Rebecca, Denig, Petra, Ailabouni, Nagham and López-Toribio, María (2024). Deprescribing and shared decision-making research. 12th International Shared Decision Making Conference, Lausanne, Switzerland, 7 - 10 July 2024. London, United Kingdom: BMJ Group. doi: 10.1136/bmjebm-2024-sdc.243
2024
Conference Publication
Co-designing a consult patient decision aid for deprescribing cholinesterase inhibitors
Ailabouni, Nagham J., Thompson, Wade, Hilmer, Sarah N., Lyntara, Q., Uirke Janet, M., Bourke, Qcneece Alice, Furst, Chloe and Reeve, Emily (2024). Co-designing a consult patient decision aid for deprescribing cholinesterase inhibitors. 12th International Shared Decision Making Conference, Lausanne, Switzerland, 7 - 10 July 2024. London, United Kingdom: BMJ Group. doi: 10.1136/bmjebm-2024-sdc.4
2024
Journal Article
Comparative risk of gout flares when initiating or escalating various urate‐lowering therapy: a systematic review with network meta‐analysis
Maher, Dorsa, Reeve, Emily, Hopkins, Ashley, Tan, Jiun Ming, Tantiongco, Mahsa, Ailabouni, Nagham, Woodman, Richard, Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael (2024). Comparative risk of gout flares when initiating or escalating various urate‐lowering therapy: a systematic review with network meta‐analysis. Arthritis Care and Research, 76 (6), 871-881. doi: 10.1002/acr.25309
2024
Journal Article
Utilising a 'Community of Practice' to support pharmacists to work in residential aged care: protocol for a longitudinal evaluation
Lee, Kenneth, Etherton-Beer, Christopher, Johnson, Jacinta, Lobo, Elton, Wang, Kate, Ailabouni, Nagham, Mavaddat, Nahal, Clifford, Rhonda Marise and Page, Amy Theresa (2024). Utilising a 'Community of Practice' to support pharmacists to work in residential aged care: protocol for a longitudinal evaluation. BMJ open, 14 (5) e076856, 1-9. doi: 10.1136/bmjopen-2023-076856
2024
Journal Article
The drug burden index and level of frailty as determinants of healthcare costs in a cohort of older frail adults in New Zealand
Duncan, Shnece, Bergler, Hans Ulrich, Menclova, Andrea, Pickering, John W., Nishtala, Prasad S., Ailabouni, Nagham, Hilmer, Sarah N., Mangin, Dee and Jamieson, Hamish (2024). The drug burden index and level of frailty as determinants of healthcare costs in a cohort of older frail adults in New Zealand. Value in Health Regional Issues, 41, 72-79. doi: 10.1016/j.vhri.2023.11.009
2024
Journal Article
Medicines regimens charted for older people living in residential aged care: a repeated cross-sectional study describing the number of medicines, regimen complexity, high-risk prescribing, and potential underprescribing
Page, Amy Theresa, Potter, Kathleen, Lee, Georgie, Almutairi, Hend, Lee, Kenneth, Wang, Kate, Ailabouni, Nagham and Etherton-Beer, Christopher (2024). Medicines regimens charted for older people living in residential aged care: a repeated cross-sectional study describing the number of medicines, regimen complexity, high-risk prescribing, and potential underprescribing. Journal of the American Medical Directors Association, 25 (6) 104944, 11-19. doi: 10.1016/j.jamda.2024.01.013
2024
Journal Article
Partnering with a stakeholder steering group to co‐design the PRIME deprescribing conversation tool: reflections and recommendations
Ailabouni, Nagham J., Weir, Kristie Rebecca, Brandt, Nicole, Hanjani, Leila Shafiee, Green, Ariel, Thompson, Wade, Freeman, Christopher R., Mangin, Dee, Bohill, Ruth, Furst, Chloe and Reeve, Emily (2024). Partnering with a stakeholder steering group to co‐design the PRIME deprescribing conversation tool: reflections and recommendations. Basic and Clinical Pharmacology and Toxicology, 134 (1), 121-125. doi: 10.1111/bcpt.13938
2023
Conference Publication
Co-designing The Prime Tool To Empower People Living With Dementia And Their Carers To Initiate Deprescribing Conversations
Shafiee Hanjani, Leila, Weir, Kristie, Reeve, Emily, Brandt, Nicole, Tao, Eric and Ailabouni, Nagham J. (2023). Co-designing The Prime Tool To Empower People Living With Dementia And Their Carers To Initiate Deprescribing Conversations. FIP World Congress, Brisbane, QLD Australia, 24 - 28 September 2023.
2023
Conference Publication
An International Comparison Of Deprescribing Interventional Studies: How To Determine Factors That Contribute To Translational Deprescribing Success?
Elsedfy, Youmna, Mangin, Dee, Jamieson, Hamish, Bergler, Ulrich, Nishtala, Prasad, Weaver, Susan K., Reeve, Emily, Freeman, Christopher R. and Ailabouni, Nagham (2023). An International Comparison Of Deprescribing Interventional Studies: How To Determine Factors That Contribute To Translational Deprescribing Success?. FIP World Congress, Brisbane, QLD Australia, 24 - 28 September 2023.
2023
Conference Publication
Top 10 unanswered questions about quality use of medicines in people living with dementia
Tan, Edwin, Reeve, Emily, Ailabouni, Nagham, Chenoweth, Lynn, Sawan, Mouna, Nguyen, Tuan Anh, Ellett, Lisa Kalisch, Gilmartin-Thomas, Julia, Sluggett, Janet, Quirke, Lyntara and Hilmer, Sarah (2023). Top 10 unanswered questions about quality use of medicines in people living with dementia. International Social Pharmacy Workshop 2022, Sydney, NSW Australia, 11-14 July 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.sapharm.2023.04.035
2023
Conference Publication
Preventing gout flares when introducing or escalating urate-lowering therapy: a systematic review and network meta-analysis
Maher, Dorsa, Reeve, Emily, Hopkins, Ashley, Tan, Jiun Ming, Tantiongco, Mahsa, Ailabouni, Nagham, Woodman, Richard, Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael (2023). Preventing gout flares when introducing or escalating urate-lowering therapy: a systematic review and network meta-analysis. 2023 Australian Rheumatology Association (ARA) 63rd Annual Scientific Meeting, Hobart, TAS, Australia, 6–9 May 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/imj.16057
2023
Conference Publication
Attitudes of healthcare professional towards the use of parenteral methotrexate in rheumatoid arthritis patients: a qualitative study
Ming, Jiun, Reeve, Emily, Chai, Wern Chern, Ailabouni, Nagham, Proudman, Susanna and Wiese, Michael (2023). Attitudes of healthcare professional towards the use of parenteral methotrexate in rheumatoid arthritis patients: a qualitative study. 2023 Australian Rheumatology Association (ARA) 63rd Annual Scientific Meeting, Hobart, TAS, Australia, 6–9 May 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/imj.16057
2023
Journal Article
Consumer and healthcare professional led priority setting for quality use of medicines in people with dementia: gathering unanswered research questions
Reeve, Emily, Chenoweth, Lynn, Sawan, Mouna, Nguyen, Tuan Anh, Kalisch Ellett, Lisa, Gilmartin-Thomas, Julia, Tan, Edwin, Sluggett, Janet K., Quirke, Lyntara S., Tran, Kham, Ailabouni, Nagham, Cowan, Katherine, Sinclair, Ron, de la Perrelle, Lenore, Deimel, Judy, To, Josephine, Daly, Stephanie, Whitehead, Craig and Hilmer, Sarah N. (2023). Consumer and healthcare professional led priority setting for quality use of medicines in people with dementia: gathering unanswered research questions. Journal of Alzheimer's Disease, 91 (3), 933-960. doi: 10.3233/jad-220827
2023
Journal Article
Deprescribing anticholinergic and sedative drugs to reduce polypharmacy in frail older adults living in the community: a randomized controlled trial
Jamieson, Hamish, Nishtala, Prasad S., Bergler, Hans Ulrich, Weaver, Susan K., Pickering, John W., Ailabouni, Nagham J., Abey-Nesbit, Rebecca, Gullery, Carolyn, Deely, Joanne, Gee, Susan B., Hilmer, Sarah N. and Mangin, Dee (2023). Deprescribing anticholinergic and sedative drugs to reduce polypharmacy in frail older adults living in the community: a randomized controlled trial. The Journals of Gerontology: Series A, 78 (9), 1692-1700. doi: 10.1093/gerona/glac249
2022
Conference Publication
Preventing urate-lowering therapy induced gout flares: a systematic review and network meta-analysis
Maher, Dorsa, Reeve, Emily, Tan, Jiun Ming, Tantiongco, Mahsa M., Ailabouni, Nagham J., Hopkins, Ashley M., Woodman, Richard J., Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael D. (2022). Preventing urate-lowering therapy induced gout flares: a systematic review and network meta-analysis. APSA-ASCEPT, Perth, WA, Australia, 29 November - 2 December 2022.
2022
Conference Publication
Co-designing deprescribing guidelines’ implementation into hospital for people living with dementia
Ailabouni, Nagham J., Weir, Kristie, Maher, Dorsa, Hilmer, Sarah, Koeper, Ivanka, Russell, Patrick, Shakib, Sepehr and Reeve, Emily (2022). Co-designing deprescribing guidelines’ implementation into hospital for people living with dementia. APSA-ASCEPT, Perth, WA Australia, 29 November - 2 December 2022.
2022
Conference Publication
Attitudes of Rheumatoid Arthritis (RA) patients towards Disease Modifying Anti-rheumatic drugs (DMARD) deprescribing
Murray, Lauren, Reeve, Emily, Ailabouni, Nagham, Kalisch Ellett, Lisa and Weise, Michael (2022). Attitudes of Rheumatoid Arthritis (RA) patients towards Disease Modifying Anti-rheumatic drugs (DMARD) deprescribing. The Pharmaceutical Society of Australia, Sydney, Australia, 29-31 July 2022.
Funding
Current funding
Supervision
Availability
- Dr Nagham Ailabouni is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Leveraging implementation science concepts to improve the translation of healthcare services that improve Quality Use of Medicines
Principal Advisor
Other advisors: Associate Professor Chris Freeman
-
Doctor Philosophy
Leveraging implementation science concepts to improve the translation of healthcare services that improve Quality Use of Medicines
Principal Advisor
Other advisors: Associate Professor Chris Freeman, Associate Professor Jean Spinks
Media
Enquiries
For media enquiries about Dr Nagham Ailabouni's areas of expertise, story ideas and help finding experts, contact our Media team: